Effectiveness of preoperative nutrition and rehabilitation therapy for sarcopenia in patients undergoing hepatobiliary and pancreatic surgery

Effectiveness of preoperative nutrition and rehabilitation therapy for sarcopenia in patients undergoing hepatobiliary and pancreatic surgery - Effectiveness of preoperative nutrition and rehabilitation for sarcopenia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027682

Enrollment

400

Registered

2017-06-09

Start date

2017-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC,biliary cancer, pancreatic cancer, metastatic liver cancer, benign disease

Interventions

Nutrition Branched-chain amino acid supplementation Aminoleban EN powder mix Livact The patients in the BCAA supplementation groups took one sachet of Aminoleban and/or Livact three times dail

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patient with a malignant tumor (hepatocellular carcinoma, metastatic liver cancer, biliary cancer, pancreatic cancer) or benign hepatobiliary and pancreatic disease. 2) Hepatectomy or pancreatectomy planted patient. 3) 20 years or older. 4) Agreement is provided in a document about the participation of this study. The patients who underwent hepatectomy or pancreatectomy. he primary diseases were categorized as benign disease (n = 6; 7%), HCC (n = 21; 26%), biliary cancer (n = 9; 11%), pancreatic cancer (n = 13; 16%), metastatic liver cancer 27 (33%), and others (n = 6; 7%).

Exclusion criteria

Exclusion criteria: 1) The patient who have active diseases other than resection planned tumor 2) The patient who cannot walk 3) The patient who cannot eat 4) The patient who was judged to be inappropriate

Design outcomes

Primary

Measure	Time frame
skeletal muscle mass	—

Countries

Japan

Contacts

Public ContactMariko Tsukagoshi

Integrative Center of General Surgery, Gunma University Hospital Hepatobiliary and Pancreatic Surgery

marikot@gunma-u.ac.jp027-220-8229

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026